上海
財聯社4月20日電，利弗莫爾證券顯示，南京英派藥業股份有限公司更新聆訊后資料集，意味著該公司港交所IPO通過聆訊。
特別聲明：以上內容(如有圖片或視頻亦包括在內)為自媒體平臺“網易號”用戶上傳并發布，本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
